Published in
Wiley, British Journal of Dermatology, 3(184), p. 450-463, 2021
DOI: 10.1111/bjd.19573
Links
Tools
Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial
Journal article published in 2020 by
J. I. Silverberg 
,
D. Toth,
T. Bieber,
A. F. Alexis,
B. E. Elewski ,
A. E. Pink,
D. Hijnen,
T. N. Jensen,
B. Bang,
C. K. Olsen,
A. Kurbasic,
S. Weidinger
,
D. Toth,
T. Bieber,
A. F. Alexis,
B. E. Elewski ,
A. E. Pink,
D. Hijnen,
T. N. Jensen,
B. Bang,
C. K. Olsen,
A. Kurbasic,
S. Weidinger
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 